MCAS, Mold & Long COVID Speaker Schedule

• SIBO, fungal overgrowth, and parasitic infections are primary gut drivers of systemic mast cell activation syndrome
• Treating gut infections must be sequenced carefully as sensitive patients require mast cell stabilization before any microbial killing phase
• Histamine intolerance and MCAS are clinically distinct conditions requiring different diagnostic and treatment approaches beyond low histamine diets

• GLP-1 agonists at microdose levels show remarkable efficacy in stabilizing mast cell activation syndrome
• Mast cell dysfunction, not pathogen load alone, drives the majority of symptoms in complex chronic illness
• Therapeutic plasma exchange combined with targeted infection treatment offers significant relief for refractory MCAS

• Mast cells are ancient survival cells positioned throughout the body, not isolated allergy cells confined to the immune system
• One dysregulated cell type can simultaneously drive neurological, gastrointestinal, cardiovascular, and inflammatory symptoms across every system of the body
• MCAS does not arise in isolation but develops after years of compounding insults from infections, mold, metals, and persistent stress

• Low-dose GLP-1 medications show emerging promise for stabilizing mast cell inflammation
• Hormone imbalances, not just deficiency, can significantly worsen mast cell activation
• Aldehyde-driven endotoxins disrupt histamine metabolism through methylation bottlenecks

• Why mast cell activation must be addressed before patients can tolerate infection treatment
• How mold exposure can quietly prevent recovery in chronic Lyme patients
• Why Long COVID patients often mirror those with chronic Lyme and coinfections

• Hydrogen directly interacts with mitochondrial complex I and IV to boost ATP production
• Research shows inhaled hydrogen reduces mast cell activation and preserves the blood-brain barrier after hemorrhage
• Improved blood cell charge reduces clumping and clotting, reversing a critically high D-dimer score

• Dysregulation of the insular cortex disconnects chronic illness patients from body signals and gut instinct
• Somatic breathing practices and brain retraining rebuild the inner regulated adult needed for healing
• Separating emotional story from felt sense accelerates nervous system recovery and reduces chronic symptom burden

• Progressive mineral depletion and heavy metal accumulation drive mitochondrial dysfunction in chronic illness
• Dysbiosis and aldehyde dehydrogenase inhibition create self-reinforcing cycles of neurological and metabolic collapse
• Restoring mineral status and glutathione metabolism must precede immune activation for effective treatment sequencing

• Mast cells become hyperreactive not because they are defective but because a compromised gut barrier signals constant threat
• GLP-1 agonists at microdose levels are emerging as a first line therapy for gut driven MCAS and SIBO
• Five distinct MCAS phenotypes require different treatment approaches rather than a one size fits all mast cell stabilizer protocol

Join Drs. Gordon and Parpia for a live interactive Q&A session on MCAS, Mold, and Long COVID. They will discuss how these conditions interact and overlap, and why patients so often stay stuck when only one piece of the puzzle is addressed.

[Register to Join Us for the Q&A]

The replay will be available to all registrants following the live session.

• How to properly test your home and body for mold and mycotoxin exposure
• How to tell recent mold exposure apart from chronic, ongoing colonization
• Why hypercoagulability is an overlooked but important piece of mold illness

• Mold and mycotoxins bypass the blood-brain barrier via the olfactory nerve, driving anxiety, memory issues, and emotional volatility
• Mold suppresses immune function, opening the door for parasites and biofilm, so detox must be sequenced carefully to avoid retoxification
• Mold exposure disrupts glutamate and GABA balance, often causing freeze responses and dorsal vagal collapse rather than classic anxiety

• CIRS and the cell danger response fit together as one clinical framework
• Certain medications can unlock cells stuck in a stalled metabolic state, paving the way for the body’s healing process
• What’s really driving histamine reactivity beyond just the mast cells

• A walkthrough of fecal microbiota transplant safety, including donor screening, GMP manufacturing, and oral delivery
• SIBO may originate from large bowel dysbiosis migrating upward, not small intestine overgrowth
• Even severe MCAS patients tolerate fecal microbiota transplants well despite reacting badly to new supplements

• EMF exposure triggers mast cell activation and suppresses natural killer cells, worsening mold susceptibility and immune tolerance
• Spike protein qualifies as a synthetic toxicant driving microclotting, persistent inflammation, and reactivation of dormant infections
• BPA, formaldehyde, and pesticides deplete glutathione and dysregulate immune function, compounding total environmental toxic burden

• Mold cannot be detoxed, mycotoxins can, and confusing the two leads to incomplete and ineffective treatment approaches
• HLA-DR genes are not a destiny diagnosis and must be interpreted within a comprehensive genetic and metabolic picture
• Removing mold triggers alone is insufficient, as nervous system dysregulation and cellular metabolism must also be fully addressed

• The traditional CIRS binder protocol alone stalls recovery whereas layering bioregulators to fix immune dysfunction first accelerates detoxification tenfold
• Peptides and bioregulators used together create a synergistic effect that accelerates immune regulation far beyond what either can achieve alone
• Vaccine injury, post COVID syndrome, and CIRS all present with identical multi-system immune dysregulation requiring the same individualized treatment approach

• Bartonella and tick-borne infections can mimic severe psychiatric disorders in children and resolve with targeted antimicrobial treatment
• Mold exposure, gut dysbiosis, and heavy metal burden create the toxic load that permits neuroinflammation to take hold
• PANS and PANDAS require identifying the infectious driver first before considering IVIG or plasmapheresis for lasting clinical progress

• Lyme and mold drive the same pro-inflammatory cytokines and must be addressed simultaneously for full recovery
• Treatment resistance often reflects immune terrain dysfunction, biofilm persistence, and mycotoxin-driven protein synthesis impairment
• Healing requires addressing self-worth, nervous system dysregulation, and microbiome restoration beyond antimicrobial and detox protocols

• Spike protein acts as an immune amplifier, waking dormant Lyme, EBV, and mycoplasma infections patients never knew they carried
• Long COVID is driving a measurable rise in ferritin, blood sugar dysregulation, and whole-body inflammatory burden in complex patients
• Removing the trigger is only step one, gut integrity, vagal tone, and cellular metabolism must all be rebuilt for full recovery

• Metformin and senolytics promote autophagy, reduce inflammation, and support tissue regeneration
• Dysregulated TLR4 pathways connect COVID, mold, and Lyme to a unified inflammatory cascade
• Systems biology frameworks reveal shared inflammatory mechanisms across sepsis, aging, and Long COVID

• One-size-fits-all testing fails complex, chronically ill patients
• Hormonal dysregulation and stealth infections warrant thorough, targeted diagnostic follow-up
• High mycotoxin loads signal it’s time to dig much deeper

• Quantitative antibody measurement reveals three distinct Long COVID subtypes: hypoimmune, hyperimmune, and mid-range presentations
• Antibody quality and concentration gaps identify persistent viral infection, guiding targeted monoclonal antibody and protein vaccine interventions
• Hyperimmune responses drive autoimmunity and mast cell activation through IgE isotype switching linked to spike protein persistence

• SPECT imaging reveals measurable neuroinflammation and functional deficits in Long COVID patients
• COVID reactivates latent co-infections, driving limbic system dysregulation and mast cell activation
• Neuromodulation and limbic system calming must precede antimicrobial and mitochondrial interventions

• Shared diagnoses mask vast biochemical and genetic differences between patients
• Cell Danger Response research confirms 75% metabolomic variation across patients
• Treatment must adapt continuously as each patient reveals unexpected biological surprises

• Metaflammation creates a self-reinforcing cycle across the gut, brain, adrenals, and hormones that standard labs consistently fail to capture
• Chronic inflammation accelerates telomere shortening, undermining cellular repair and leaving Long COVID patients vulnerable to further disease progression
• Peptides, exosomes, and individualized treatment sequencing succeed where standard functional medicine protocols consistently fail in Long COVID patients

• Cerebellar dysfunction leaves the immune system uncoordinated and unable to fight off mold, tick-borne illness, and Long COVID effectively
• Primed glial cells activated by COVID, stress, or infection drive brain fog, executive dysfunction, and autonomic dysregulation in chronic illness patients
• Specialized video nystagmography goggles reveal invisible neurological imbalances that correlate directly with vertigo, POTS, and cognitive symptoms